Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's disease
Providers
Industry Voices—The beginning of the end for Alzheimer's?
We are on the cusp of transforming Alzheimer’s care, but we aren’t positioned to take this win.
Alvaro Pascual-Leone, M.D., Ph.D.
Oct 26, 2023 12:00pm
CMS unveils details on coverage for new Alzheimer's meds
Jun 23, 2023 11:00am
Not covering Alzheimer’s drugs could be costly for Medicare
Jun 12, 2023 8:00am
CMS won’t cover lecanemab without more proof of its effectiveness
Mar 14, 2023 5:00pm
Optum report: Alzheimer's drugs key for payers to watch in Q1
Feb 24, 2023 4:30pm
CMS wants more data before rethinking Alzheimer's drug coverage
Feb 23, 2023 3:50pm